Elisabeta Otilia Benea *
* Dr. Elisabeta Otilia Benea – medic primar boli infecțioase, doctor în medicină, șef secție – Institutul de Boli lnfecțioase “Prof Dr. Matei Balș”, șef lucrări U.M.F Carol Davila, București
Abstract
In the past 10 years, therapeutic strategies for HIV infection have expanded dramatically from treatment with a single medication to combinations with as many as three different classes of antiviral agents, and ongoing studies are exploring the addition of biologic response modifiers to standard treatment. Our currently antiretroviral armamentarium includes RTls (both nucleoside and nonnucleoside), which act at the early stage of replication, and inhibitors of viral protease, which work in the later stage after viral integration.